Short-course RT Followed by NALIRIFOX Plus Pucotenlimab as Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer With MSS/pMMR
Clinical trial NCT07651007 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07651007
- Sponsor
- Wang Xin
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-31
- Primary completion
- 2027-12-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.